Expression and activation of EphA4 in the human brain after traumatic injury

T Frugier, A Conquest, C McLean… - … of Neuropathology & …, 2012 - academic.oup.com
T Frugier, A Conquest, C McLean, P Currie, D Moses, Y Goldshmit
Journal of Neuropathology & Experimental Neurology, 2012academic.oup.com
Glial scars that consist predominantly of reactive astrocytes create a major barrier to
neuronal regeneration after traumatic brain injury (TBI). In experimental TBI, Eph receptors
and their ephrin ligands are upregulated on reactive astrocytes at injury sites and inhibit
axonal regeneration, but very little is known about Eph receptors in the human brain after
TBI. A better understanding of the functions of glial cells and their interactions with
inflammatory cells and injured axons will allow the development of treatment strategies that …
Abstract
Glial scars that consist predominantly of reactive astrocytes create a major barrier to neuronal regeneration after traumatic brain injury (TBI). In experimental TBI, Eph receptors and their ephrin ligands are upregulated on reactive astrocytes at injury sites and inhibit axonal regeneration, but very little is known about Eph receptors in the human brain after TBI. A better understanding of the functions of glial cells and their interactions with inflammatory cells and injured axons will allow the development of treatment strategies that may promote regeneration. We analyzed EphA4 expression and activation in postmortem brain tissue from 19 patients who died after acute closed head injury and had evidence of diffuse axonal injury and 8 controls. We also examined downstream pathways that are mediated by EphA4 in human astrocyte cell cultures. Our results indicate that, after TBI in humans, EphA4 expression is upregulated and is associated with reactive astrocytes. The expression was increased shortly after the injury and remained activated for several days. EphA4 activation induced under inflammatory conditions in vitro was inhibited using unclustered EphA4 ligand. These results suggest that blocking EphA4 activation may represent a therapeutic approach for TBI and other types of brain injuries in humans.
Oxford University Press